https://pubmed.ncbi.nlm.nih.gov/38112103
The abstract discusses the approval and efficacy of Somatrogon, a once-weekly long-acting growth hormone injection, for the treatment of pediatric growth hormone deficiency, and compares it to other long-acting growth hormone products.